ArticleMedical science monitor : international medical journal of experimental and clinical research2026
Evaluating Pharmacokinetics and Toxicity of Potential Therapeutics Against Enterococcus faecalis in Endodontic Pathologies.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND This study explores pharmacokinetic profiles and safety parameters of candidate therapeutics targeting Enterococcus faecalis in endodontic infections. It examines absorption, distribution, metabolism, excretion characteristics, toxicity risk, and biocompatibility with periapical tissues. The objective is to identify clinically safe and efficacious compounds for endodontic application. MATERIAL AND METHODS Quantum chemical and molecular docking techniques evaluated the electronic structures of 5 bioactive compounds - 2-hydroxyethyl methacrylate, dimethyl adipate, dimethyl glutarate, dimethyl succinate, and ethylene glycol dimethyl acrylate - and their interactions with E. faecalis, a key endodontic infectious pathogen. These methods offer insights into binding affinities and drug behavior within the endodontic environment. Pharmacokinetic (ADME) studies were used to evaluate drug absorption and distribution, while toxicity assessments predicted potential adverse effects on organs, thereby ensuring safe and effective treatment of endodontic lesions. RESULTS We used Gaussian16 software to heighten the structures of 2-hydroxyethyl methacrylate, which enhances adhesion, along with dimethyl adipate, dimethyl glutarate, and dimethyl succinate, as compounds with probable endodontic applications. ADMET analyses were used to screen candidates for pharmacokinetic suitability and safety. Molecular docking was accomplished against the target protein E. faecalis, using AutoDock Vina and AutoDock Tools. Ethylene glycol dimethyl acrylate is the most promising candidate for endodontic applications owing to its binding affinity, metabolic stability, and efficient clearance. 2-Hydroxyethyl methacrylate has promising electrostatic potential and pharmacokinetics, while dimethyl succinate has low binding affinity and carcinogenicity concerns. CONCLUSIONS Results suggests that 2-hydroxyethyl methacrylate, dimethyl adipate, dimethyl glutarate, dimethyl succinate, and ethylene glycol dimethyl acrylate bind to E. faecalis, a key pathogen in endodontic infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.